← Back to Search

Keratoprosthesis

CorNeat KPro for Corneal Diseases

N/A
Waitlist Available
Research Sponsored by CorNeat Vision Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights

Summary

This trial tests the safety and effectiveness of an artificial cornea called the CorNeat Keratoprosthesis. It targets patients with corneal blindness who can't have traditional transplants. The synthetic cornea is implanted to replace the damaged natural one, helping to improve vision.

Eligible Conditions
  • Corneal Diseases
  • Corneal Opacity
  • Corneal Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety Endpoint as determined by the frequency and severity of all unanticipated adverse device-related events (UADE)
Secondary study objectives
Primary effectiveness Endpoint - Device retention rate
Secondary effectiveness Endpoint - Improvement in BCDVA

Trial Design

1Treatment groups
Experimental Treatment
Group I: CorNeat KProExperimental Treatment1 Intervention
Intraocular implantation of the CorNeat KPro

Find a Location

Who is running the clinical trial?

CorNeat Vision Ltd.Lead Sponsor
3 Previous Clinical Trials
80 Total Patients Enrolled
1 Trials studying Corneal Diseases
40 Patients Enrolled for Corneal Diseases
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top